Full project title:
An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes
Start date:
01 Feb 2018
Duration:
6 years (incl. a 12-month project extension)
Participants:
9 institutions from 4 different European countries
Horizon 2020 funding:
5.5 million € (5,536,775 €)
Project coordinator:
Prof. Dr. Harald Schmidt
Project manager:
Ameli Schwalber (concentris)
Number of work packages:
5
EU project information:
